Elevation Oncology
Stock Forecast, Prediction & Price Target

Elevation Oncology Financial Estimates

Elevation Oncology Revenue Estimates

Elevation Oncology EBITDA Estimates

Elevation Oncology Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $16.24M
Low: $16.24M
High: $16.24M
avg. 0%
Avg: $88.57M
Low: $88.57M
High: $88.57M
avg. 445.09%
Net Income
 
% change YoY
$-32.03M
 
N/A
$-95.08M
 
-196.76%
$-45.70M
 
51.93%
Avg: $-62.20M
Low: $-44.98M
High: $-25.55M
avg. -36.09%
Avg: $-81.94M
Low: $-61.33M
High: $-21.46M
avg. -31.73%
Avg: $-41.29M
Low: $-41.29M
High: $-41.29M
avg. 49.60%
Avg: $-18.26M
Low: $-18.26M
High: $-18.26M
avg. 55.76%
EBITDA
 
% change YoY
$-32.02M
 
N/A
$-94.54M
 
-195.20%
$-41.46M
 
56.14%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$1.38
 
N/A
-$4.09
 
-196.37%
-$1.34
 
67.23%
Avg: -$0.98
Low: -$1.32
High: -$0.75
avg. 26.97%
Avg: -$1.12
Low: -$1.8
High: -$0.63
avg. -14.79%
Avg: -$1.21
Low: -$1.21
High: -$1.21
avg. -7.86%
Avg: -$0.54
Low: -$0.54
High: -$0.54
avg. 55.76%
Operating Expenses
 
% change YoY
$32.04M
 
N/A
$94.54M
 
195.04%
$45.44M
 
-51.93%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Elevation Oncology stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 9.38% in 2025-2028.

We have gathered data from 6 analysts. Their low estimate is -44.98M, average is -62.20M and high is -25.55M.

What is Elevation Oncology stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 111.27% in 2025-2028.

We have gathered data from 6 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.

What is Elevation Oncology stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 15.01% in 2025-2028.

We have gathered data from 6 analysts. Their low earnings per share estimate is -$1.32, average is -$0.98 and high is $-0.75.

What is the best performing analyst?

In the last twelve months analysts have been covering Elevation Oncology stock. The most successful analyst is Biren Amin.